Français
ItalianoBond Eli Lilly 5.1% ( US532457CN68 ) in USD
| Issuer | Eli Lilly | ||||||||
| Market price |  93.02 % ▼ |
||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US532457CN68 ( in USD )
|
||||||||
| Interest rate | 5.1% per year ( payment 2 times a year) | ||||||||
| Maturity | 09/02/2064 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | / | ||||||||
| Total amount | / | ||||||||
| Cusip | 532457CN6 | ||||||||
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) | ||||||||
| Moody's rating | Aa3 ( High grade - Investment-grade ) | ||||||||
| Next Coupon | 09/02/2027 ( In 166 days ) | ||||||||
| Detailed description |
Eli Lilly and Company is a global pharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products and biologicals. The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457CN68, pays a coupon of 5.1% per year. The coupons are paid 2 times per year and the Bond maturity is 09/02/2064 The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457CN68, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457CN68, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||